Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcin Kowanetz

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|April 7, 2009
G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse modelsFarbod Shojaei, Xiumin Wu, Xueping Qu, et al.
Plos One|February 3, 2021
C-reactive protein reduction post treatment is associated with improved survival in atezolizumab (anti-PD-L1) treated non-small cell lung cancer patientsNamrata S Patil, Wei Zou, Simonetta Mocci, et al.
The Journal of Pathology|May 22, 2012
Differential drug class-specific metastatic effects following treatment with a panel of angiogenesis inhibitorsAlicia S Chung, Marcin Kowanetz, Xiumin Wu, et al.
The Journal of Biological Chemistry|March 2, 2012
Transcriptional induction of salt-inducible kinase 1 by transforming growth factor β leads to negative regulation of type I receptor signaling in cooperation with the Smurf2 ubiquitin ligasePeter Lönn, Michael Vanlandewijck, Erna Raja, et al.
The Journal of Biological Chemistry|July 23, 2003
Identification of a novel proline-arginine motif involved in CIN85-dependent clustering of Cbl and down-regulation of epidermal growth factor receptorsKatarzyna Kowanetz, Iwona Szymkiewicz, Kaisa Haglund, et al.
Oral Oncology|March 30, 2017
Characterization of PD-L1 expression and immune cell infiltration in nasopharyngeal cancerOscar Siu Hong Chan, Marcin Kowanetz, Wai Tong Ng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2008
Blocking vascular endothelial growth factor-A inhibits the growth of pituitary adenomas and lowers serum prolactin level in a mouse model of multiple endocrine neoplasia type 1Nina Korsisaari, Jed Ross, Xiumin Wu, et al.
Molecular Biology of the Cell|April 20, 2004
CIN85 associates with multiple effectors controlling intracellular trafficking of epidermal growth factor receptorsKatarzyna Kowanetz, Koraljka Husnjak, Daniela Höller, et al.
Cancer Immunology Research|January 31, 2018
Prognostic Significance of PD-L1<sup>+</sup> and CD8<sup>+</sup> Immune Cells in HPV<sup>+</sup> Oropharyngeal Squamous Cell CarcinomaBenjamin Solomon, Richard J Young, Mathias Bressel, et al.
Journal for Immunotherapy of Cancer|September 13, 2019
Late-differentiated effector neoantigen-specific CD8+ T cells are enriched in peripheral blood of non-small cell lung carcinoma patients responding to atezolizumab treatmentMichael Fehlings, Suchit Jhunjhunwala, Marcin Kowanetz, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Proceedings of the National Academy of Sciences of the United States of America|April 7, 2009
G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse modelsFarbod Shojaei, Xiumin Wu, Xueping Qu, et al.
Plos One|February 3, 2021
C-reactive protein reduction post treatment is associated with improved survival in atezolizumab (anti-PD-L1) treated non-small cell lung cancer patientsNamrata S Patil, Wei Zou, Simonetta Mocci, et al.
The Journal of Pathology|May 22, 2012
Differential drug class-specific metastatic effects following treatment with a panel of angiogenesis inhibitorsAlicia S Chung, Marcin Kowanetz, Xiumin Wu, et al.
The Journal of Biological Chemistry|March 2, 2012
Transcriptional induction of salt-inducible kinase 1 by transforming growth factor β leads to negative regulation of type I receptor signaling in cooperation with the Smurf2 ubiquitin ligasePeter Lönn, Michael Vanlandewijck, Erna Raja, et al.
The Journal of Biological Chemistry|July 23, 2003
Identification of a novel proline-arginine motif involved in CIN85-dependent clustering of Cbl and down-regulation of epidermal growth factor receptorsKatarzyna Kowanetz, Iwona Szymkiewicz, Kaisa Haglund, et al.
Oral Oncology|March 30, 2017
Characterization of PD-L1 expression and immune cell infiltration in nasopharyngeal cancerOscar Siu Hong Chan, Marcin Kowanetz, Wai Tong Ng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2008
Blocking vascular endothelial growth factor-A inhibits the growth of pituitary adenomas and lowers serum prolactin level in a mouse model of multiple endocrine neoplasia type 1Nina Korsisaari, Jed Ross, Xiumin Wu, et al.
Molecular Biology of the Cell|April 20, 2004
CIN85 associates with multiple effectors controlling intracellular trafficking of epidermal growth factor receptorsKatarzyna Kowanetz, Koraljka Husnjak, Daniela Höller, et al.
Cancer Immunology Research|January 31, 2018
Prognostic Significance of PD-L1<sup>+</sup> and CD8<sup>+</sup> Immune Cells in HPV<sup>+</sup> Oropharyngeal Squamous Cell CarcinomaBenjamin Solomon, Richard J Young, Mathias Bressel, et al.
Journal for Immunotherapy of Cancer|September 13, 2019
Late-differentiated effector neoantigen-specific CD8+ T cells are enriched in peripheral blood of non-small cell lung carcinoma patients responding to atezolizumab treatmentMichael Fehlings, Suchit Jhunjhunwala, Marcin Kowanetz, et al.
Pageof 5